Envista Holdings Corporation
NVSTHealthcareNASDAQMedical Instruments & Supplies · Last scanned Jun 3, 2026
Scan Results
Daily timeframeEnvista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. Valued at $3.73B, NVST is a mid-cap name in its sector. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
Market Cap
$3.73B
Beta
0.93
P/E (TTM)
55.95
P/E (Fwd)
14.62
EPS (TTM)
$0.41
EPS (Fwd)
$1.57
ROE
2.2%
ROA
3.0%
Cash
$1.08B
Total Debt
$1.59B
Free CF
$216.3M
52W Change
22.4%
Annual Financials
Cash vs Debt
The company holds $1.08B in cash, though total debt stands at $1.59B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $216.3M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 2.2% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.0% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $2.57B (2022) to $2.72B (2025).
At over 50x earnings, NVST carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Envista Holdings Corporation and its sector.